Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Targeting genetic dependencies of myogenic cancer stem cells in embryonal rhabdomyosarcoma
FY 2022-23
Summary
Rhabdomyosarcoma (RMS) is a disease in which cancer forms in the muscle tissue and it is the most common type of soft-tissue sarcoma found in children. Embryonal RMS (eRMS) is the most common subtype of RMS, mainly affecting the head and neck area of young children. Although the cause and mechanism of eRMS development is unclear, histological analysis of tumor samples suggest that muscle stem cells, which are cells responsible for muscle regeneration following muscle injury, could potentially be the origin of this cancer. Normal muscle stem cells are kept in a dormant state until they are activated for differentiation into muscle tissue. Various regulatory factors are responsible for controlling this differentiation process in healthy muscle stem cells. However, eRMS cells are unable to differentiate into muscle fibers and exhibit characteristics resembling stem cells that are more prone to proliferation. Previous studies have shown that the uncontrolled growth of eRMS tumor cells can be stopped by restoring the ability of these eRMS cells to differentiate. My research project will focus on identifying the molecular pathways and mechanisms that drive impaired differentiation in eRMS cells. Through the use of unbiased high-throughput genetic screens, I hope to discover genes that can be targeted to restore differentiation in eRMS and to identify pharmacological compounds that can target these genes therapeutically. Overall, my research project aims to determine novel molecular mechanisms that drive impaired differentiation in eRMS and reveal potential drugs to promote differentiation and prevent eRMS tumor growth.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486019
Name
Li Shulei
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Targeting genetic dependencies of myogenic cancer stem cells in embryonal rhabdomyosarcoma
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biochemistry; Cancer; Cancer Of The Musculoskeletal System; Cancer Stem Cells; Cancer Therapeutics; Cell Differentiation And Tumorigenesis; High Throughput Drug Screen; High Throughput Genetic Screen; Molecular Biology; Rhabdomyosarcoma
Abstract
Rhabdomyosarcoma (RMS) is a disease in which cancer forms in the muscle tissue and it is the most common type of soft-tissue sarcoma found in children. Embryonal RMS (eRMS) is the most common subtype of RMS, mainly affecting the head and neck area of young children. Although the cause and mechanism of eRMS development is unclear, histological analysis of tumor samples suggest that muscle stem cells, which are cells responsible for muscle regeneration following muscle injury, could potentially be the origin of this cancer. Normal muscle stem cells are kept in a dormant state until they are activated for differentiation into muscle tissue. Various regulatory factors are responsible for controlling this differentiation process in healthy muscle stem cells. However, eRMS cells are unable to differentiate into muscle fibers and exhibit characteristics resembling stem cells that are more prone to proliferation. Previous studies have shown that the uncontrolled growth of eRMS tumor cells can be stopped by restoring the ability of these eRMS cells to differentiate. My research project will focus on identifying the molecular pathways and mechanisms that drive impaired differentiation in eRMS cells. Through the use of unbiased high-throughput genetic screens, I hope to discover genes that can be targeted to restore differentiation in eRMS and to identify pharmacological compounds that can target these genes therapeutically. Overall, my research project aims to determine novel molecular mechanisms that drive impaired differentiation in eRMS and reveal potential drugs to promote differentiation and prevent eRMS tumor growth.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Li, Shulei
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~